The independent source for health policy research, polling, and news.
Showing 201 - 220 of 831
The program, which will roll out next year in three parts of the country, seeks to encourage workers on the company’s health plan to choose doctors that have been identified as providing “appropriate, effective and cost-efficient care.”
Ride-sharing companies promise better service for enrollees and lower costs for states. But the services are not for everyone on Medicaid.
Census officials said most of the drop in health coverage was related to a 0.7% decline in Medicaid. The number of people with private insurance remained steady.
Health experts say the little-used benefit represents a lost opportunity for older adults to improve their health — and for the program to save money by preventing costly complications from diabetes and chronic kidney disease.
Critics worry the delays come at a steep cost: Medicare paying for millions of unnecessary exams and patients subject to radiation for no medical benefit.
The patient is from Mississippi. The surgeon is from Wisconsin. They meet in a Mexican resort for knee replacement surgery. Because the care costs so much less than in the U.S, the patient’s health plan pays her $5,000.
HHS secretary announces a preliminary plan Wednesday to allow Americans to import certain lower-cost drugs from Canada. Manufacturers were quick to criticize the plan, saying it does not guarantee the safety of drugs coming into the country.
Only about 12% of dialysis patients get their treatment at home and the initiative aims to dramatically increase that number and move patients out of costly dialysis centers. It would also add provisions to boost the annual number of kidneys available for transplants.
A pricing tool embedded in their electronic health record and prescribing system lets doctors see how much patients will pay out-of-pocket based on their insurance and the pharmacy. But doctors have been slow to adopt the technology, which has limitations.
Colorado, Florida and Vermont — with the support of President Donald Trump — are exploring plans to bring drugs across the border from Canada to help lower costs.
More than 95% of the Arkansas residents targeted by the state’s Medicaid work requirement were already working or met the criteria to be exempted from the mandate, according to a study in the New England Journal of Medicine.
While national business groups fight the single-payer concept, the founder and CEO of a large Pennsylvania picture frame manufacturer tries to convince other employers that it’s the only way to control costs and fix the U.S. health system.
Walmart, the nation’s largest private employer, is recommending that employees and dependents use one of 800 imaging centers identified as providing trustworthy care.
Psychiatric treatment for children in Medicaid managed-care plans in Missouri has declined and suicide risks are up, reveals a study sponsored by the state hospital association.
Work helps make people healthier, CMS chief Seema Verma said in approving Utah’s waiver request to tie government health benefits to employment or volunteer work. But Judge James Boasberg has said that isn’t the goal of Medicaid.
The decision applies only to Kentucky and Arkansas, and many experts expect the administration and other conservative states to continue to move forward on rules that would limit coverage for people who don’t work.
Colorado officials say hospitals are better off financially after the state expanded coverage to more low-income residents, but that hasn’t stopped them from shifting more costs to other insured patients.
A federal district judge appeared skeptical of the arguments by the Justice Department and Arkansas and Kentucky that their programs should mandate that some enrollees work.
The Food and Drug Administration claims CanaRX, a company used by more than 500 cities, counties and school districts to help their employees get cheaper drugs from overseas, has sent “unapproved” and “misbranded” drugs to U.S. consumers, jeopardizing their safety.
The state’s governor said the plan has the full support of the White House. But the Trump administration was noncommittal about whether allowing states to buy and import cheaper drugs from up north could be the answer to the nation’s drug-pricing problem.
Stay informed by signing up for the Morning Briefing and other emails:
© 2026 鶹Ů